01 2ALCON LABS INC
02 15GLENMARK SPECLT
01 18791154
02 19078923
03 19370483
04 19533053
05 19750754
06 19937189
07 110016443
08 110376526
09 110517880
10 110548907
11 110561672
12 110646500
13 110758550
14 110765686
15 111400101
16 111679210
17 112064442
01 17Blank
01 10Y
02 7Blank
01 22032-05-19
02 142034-09-04
03 12038-09-03
Patent Expiration Date : 2032-05-19
US Patent Number : 8791154
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206276
Patent Use Code : U-1680
Delist Requested :
Patent Use Description : TREATMENT OF OCULAR IT...
Patent Expiration Date : 2032-05-19
Patent Expiration Date : 2032-05-19
US Patent Number : 9533053
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206276
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-05-19
Patent Expiration Date : 2034-09-04
MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
US Patent Number : 10765686
Drug Substance Claim :
Drug Product Claim :
Application Number : 211746
Patent Use Code : U-3295
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-09-04
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-09-04
MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
US Patent Number : 10758550
Drug Substance Claim :
Drug Product Claim :
Application Number : 211746
Patent Use Code : U-3296
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-09-04
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-09-04
MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
US Patent Number : 10646500
Drug Substance Claim :
Drug Product Claim :
Application Number : 211746
Patent Use Code : U-3297
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-09-04
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-09-04
MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
US Patent Number : 10548907
Drug Substance Claim :
Drug Product Claim :
Application Number : 211746
Patent Use Code : U-3297
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-09-04
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-09-04
MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
US Patent Number : 11400101
Drug Substance Claim :
Drug Product Claim :
Application Number : 211746
Patent Use Code : U-3297
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-09-04
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-09-04
MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
US Patent Number : 12064442
Drug Substance Claim :
Drug Product Claim :
Application Number : 211746
Patent Use Code : U-3297
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-09-04
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-09-04
MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
US Patent Number : 10016443
Drug Substance Claim :
Drug Product Claim :
Application Number : 211746
Patent Use Code : U-3297
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-09-04
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-09-04
MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
US Patent Number : 10517880
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 211746
Patent Use Code : U-3297
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-09-04
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
